Skip to content
Menu

Investor Information

Icon label

Investor Presentation

Explore our recent performance and strategic outlook. Our investor presentation is now available for viewing.

Shareholder Information

Please note that any opinions, estimates or forecasts regarding NeuPath’s performance made by this analyst is theirs alone and does not represent opinions, forecasts or predictions of NeuPath or its management. NeuPath does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Common Shares Outstanding 56.4 million

Share Capital as of December 31, 2024

TSX VENTURE EXCHANGE

  • Loading stock data...

The NeuPath common shares started trading on the TSX Venture Exchange on July 6, 2020.

Investor Events & Presentations

2024 Bloom Burton & Co. Healthcare Investor Conference
Wednesday, April 17, 2024, 11 a.m. ET

Financial Reporting

NeuPath regulatory filings can be found on the Sedar website.

2024

Financial Statements
INVESTOR PRESS RELEASE
ANNUAL INFORMATION FORM
MANAGEMENT INFORMATION CIRCULAR

2023

Financial Statements
INVESTOR PRESS RELEASE
ANNUAL INFORMATION FORM
MANAGEMENT INFORMATION CIRCULAR

View Prior Years’ Statements

Registered shareholders with questions regarding share certificates, change of address for your account or share transfers should contact:

Transfer Agent

TSX Trust Company
301-100 Adelaide Street West
Toronto, ON M5H 4H1
(416) 361-0930
[email protected]

Independent Auditors

Ernst & Young LLP
100 Adelaide Street West
Toronto, ON M5J 2T6

Contact Investor Relations